TCM, traditional Chinese medicine

TCM,中药
  • 文章类型: Journal Article
    急性肺损伤(ALI)是临床上严重的肺部疾病,发病率和死亡率都很高。尤其是,2019年冠状病毒病(COVID-19)对全球政府健康构成严重威胁。它几乎分布在宇宙的各个角落,COVID-19防控形势依然严峻。中医药在疾病的预防和治疗中起着至关重要的作用。目前,缺乏治疗这些疾病的药物,因此有必要开发治疗COVID-19相关ALI的药物。苦参(D.Don)Hara是of科的一年生植物,也是中国历史悠久的传统医学之一。近年来,其根茎(药用部位)因其显著的抗炎作用而受到国内外学者的关注,抗菌和抗癌活性。它可以在SARS-COV-2上使用多种成分,目标,和路径,并对冠状病毒病2019(COVID-19)相关急性肺损伤(ALI)有一定影响。然而,对其地上部分(包括茎和叶)的系统研究很少,其潜在的治疗机制尚未研究。使用TCMSP数据库收集了F.dibotrys根茎的植物化学成分。并通过代谢组学检测了F.dibotrys的地上部分的代谢产物。通过PharmMapper网站工具预测了F.dibotrys的植物化学目标。从GeneCards中检索到COVID-19和ALI相关基因。通过metscape生物信息学工具,通过基因本体论(GO)和KEGG富集了F.dibotrys中COVID-19和ALI相关基因的交叉靶标和活性植物化学物质。使用Cytoscape软件建立并分解了相互作用的网络进入活性植物化学物质和抗COVID-19和ALI靶标。DiscoveryStudio(2019版)用于对具有抗COVID-19和ALI靶标的关键活性植物化学物质进行分子对接。我们从F.dibotrys的地上部分鉴定出1136种化学物质,其中活性类黄酮和酚类化学物质47种。从F.dibotrys的根茎中搜索到了总共61种化学物质,其中15种是活性化学物质。因此,在F.dibotrys的地上部分和根茎上有6种常见的关键活性化学物质,89这些植物化学物质的潜在目标,和211个COVID-19和ALI相关基因。GO富集表明F.dibotrys可能参与影响包含许多生物学过程的基因靶标,例如,巨核细胞分化的负调控,调节DNA代谢过程,这可以归结为其抗COVID-19相关的ALI效应。KEGG通路表明病毒致癌作用,剪接体,沙门氏菌感染,冠状病毒病-COVID-19,军团菌病和人类免疫缺陷病毒1感染途径是困扰F.dibotrys抗COVID-19相关ALI作用的主要途径。分子对接证实了F.dibotrys的6种关键活性植物化学物质,如木犀草素,(+)-表儿茶素,槲皮素,异鼠李素,(+)-儿茶素,和(-)-儿茶素没食子酸酯,可以与内核治疗靶点NEDD8、SRPK1、DCUN1D1和PARP1结合。体外活性实验表明,在一定范围内,随着浓度的增加,二博特草生部分和根茎的总抗氧化能力增加。此外,作为一个整体,黄曲霉地上部分的抗氧化能力强于根茎。我们的研究为进一步探索F.dibotrys的抗COVID-19相关ALI化学成分和机制提供了线索,并为开发基于F.dibotrys植物化学物质的现代抗COVID-19相关ALI药物提供了科学依据。我们还充分开发了F.dibotrys的地上部分的药用价值,能有效避免资源的浪费。同时,我们的工作为整合代谢组学提供了新的策略,网络药理学,和分子对接技术是识别对中药药理作用有效的有效成分和机制的有效途径。
    Acute lung injury (ALI) is a clinically severe lung illness with high incidence rate and mortality. Especially, coronavirus disease 2019 (COVID-19) poses a serious threat to world wide governmental fitness. It has distributed to almost from corner to corner of the universe, and the situation in the prevention and control of COVID-19 remains grave. Traditional Chinese medicine plays a vital role in the precaution and therapy of sicknesses. At present, there is a lack of drugs for treating these diseases, so it is necessary to develop drugs for treating COVID-19 related ALI. Fagopyrum dibotrys (D. Don) Hara is an annual plant of the Polygonaceae family and one of the long-history used traditional medicine in China. In recent years, its rhizomes (medicinal parts) have attracted the attention of scholars at home and abroad due to their significant anti-inflammatory, antibacterial and anticancer activities. It can work on SARS-COV-2 with numerous components, targets, and pathways, and has a certain effect on coronavirus disease 2019 (COVID-19) related acute lung injury (ALI). However, there are few systematic studies on its aerial parts (including stems and leaves) and its potential therapeutic mechanism has not been studied. The phytochemical constituents of rhizome of F. dibotrys were collected using TCMSP database. And metabolites of F. dibotrys\' s aerial parts were detected by metabonomics. The phytochemical targets of F. dibotrys were predicted by the PharmMapper website tool. COVID-19 and ALI-related genes were retrieved from GeneCards. Cross targets and active phytochemicals of COVID-19 and ALI related genes in F. dibotrys were enriched by gene ontology (GO) and KEGG by metscape bioinformatics tools. The interplay network entre active phytochemicals and anti COVID-19 and ALI targets was established and broke down using Cytoscape software. Discovery Studio (version 2019) was used to perform molecular docking of crux active plant chemicals with anti COVID-19 and ALI targets. We identified 1136 chemicals from the aerial parts of F. dibotrys, among which 47 were active flavonoids and phenolic chemicals. A total of 61 chemicals were searched from the rhizome of F. dibotrys, and 15 of them were active chemicals. So there are 6 commonly key active chemicals at the aerial parts and the rhizome of F. dibotrys, 89 these phytochemicals\'s potential targets, and 211 COVID-19 and ALI related genes. GO enrichment bespoken that F. dibotrys might be involved in influencing gene targets contained numerous biological processes, for instance, negative regulation of megakaryocyte differentiation, regulation of DNA metabolic process, which could be put down to its anti COVID-19 associated ALI effects. KEGG pathway indicated that viral carcinogenesis, spliceosome, salmonella infection, coronavirus disease - COVID-19, legionellosis and human immunodeficiency virus 1 infection pathway are the primary pathways obsessed in the anti COVID-19 associated ALI effects of F. dibotrys. Molecular docking confirmed that the 6 critical active phytochemicals of F. dibotrys, such as luteolin, (+) -epicatechin, quercetin, isorhamnetin, (+) -catechin, and (-) -catechin gallate, can combine with kernel therapeutic targets NEDD8, SRPK1, DCUN1D1, and PARP1. In vitro activity experiments showed that the total antioxidant capacity of the aerial parts and rhizomes of F. dibotrys increased with the increase of concentration in a certain range. In addition, as a whole, the antioxidant capacity of the aerial part of F. dibotrys was stronger than that of the rhizome. Our research afford cues for farther exploration of the anti COVID-19 associated ALI chemical compositions and mechanisms of F. dibotrys and afford scientific foundation for progressing modern anti COVID-19 associated ALI drugs based on phytochemicals in F. dibotrys. We also fully developed the medicinal value of F. dibotrys\' s aerial parts, which can effectively avoid the waste of resources. Meanwhile, our work provides a new strategy for integrating metabonomics, network pharmacology, and molecular docking techniques which was an efficient way for recognizing effective constituents and mechanisms valid to the pharmacologic actions of traditional Chinese medicine.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经证实:舌头图像(颜色,舌头的大小和形状以及颜色,舌苔的厚度和水分含量),根据中医理论反映全身的健康状况,已经在中国广泛使用了数千年。在这里,我们调查了舌象和舌苔微生物组在胃癌(GC)诊断中的价值。
    UNASSIGNED:从2020年5月到2021年1月,我们同时收集了中国328名GC患者(所有新诊断为GC)和304名非胃癌(NGC)参与者的舌象和舌苔样本,和16SrDNA用于表征舌苔样品的微生物组。然后,建立人工智能(AI)深度学习模型,评估舌象和舌苔微生物组在GC诊断中的价值。考虑到舌成像作为诊断工具更方便、更经济,我们于2020年5月至2022年3月在中国进一步开展了一项前瞻性多中心临床研究,招募了来自中国10个中心的937例GC患者和1911例NGC患者,以进一步评估舌象在GC诊断中的作用.此外,我们在另一个独立的外部验证队列中验证了该方法,该队列包括来自7个中心的294例GC患者和521例NGC患者.这项研究在ClinicalTrials.gov注册,NCT01090362。
    未经评估:第一次,我们发现舌象和舌苔微生物组可以作为GC诊断的工具,基于舌象的诊断模型的曲线下面积(AUC)值为0.89。基于舌苔微生物组的模型的AUC值使用属数据达到0.94,使用物种数据达到0.95。前瞻性多中心临床研究结果表明,三种基于舌象的GCs模型的AUC值在内部验证中达到0.88-0.92,在独立外部验证中达到0.83-0.88,显着优于八种血液生物标志物的组合。
    UNASSIGNED:我们的结果表明,舌头图像可作为GC诊断的稳定方法,并且显着优于常规血液生物标志物。我们开发的三种基于舌图像的AI深度学习诊断模型可用于充分区分GC患者和NGC参与者,甚至早期GC和癌前病变,如萎缩性胃炎(AG)。
    未经批准:国家重点研发计划(2021YFA0910100),浙江省中医药科技计划方案(2018ZY006),浙江省医学科技项目(2022KY114,WKJ-ZJ-2104),浙江省上消化道肿瘤研究中心(JBZX-202006),浙江省自然科学基金(HDMY22H160008),浙江省科技项目(2019C03049),国家自然科学基金(82074245,81973634,82204828),中国博士后科学基金(2022M713203)。
    UNASSIGNED: Tongue images (the colour, size and shape of the tongue and the colour, thickness and moisture content of the tongue coating), reflecting the health state of the whole body according to the theory of traditional Chinese medicine (TCM), have been widely used in China for thousands of years. Herein, we investigated the value of tongue images and the tongue coating microbiome in the diagnosis of gastric cancer (GC).
    UNASSIGNED: From May 2020 to January 2021, we simultaneously collected tongue images and tongue coating samples from 328 patients with GC (all newly diagnosed with GC) and 304 non-gastric cancer (NGC) participants in China, and 16 S rDNA was used to characterize the microbiome of the tongue coating samples. Then, artificial intelligence (AI) deep learning models were established to evaluate the value of tongue images and the tongue coating microbiome in the diagnosis of GC. Considering that tongue imaging is more convenient and economical as a diagnostic tool, we further conducted a prospective multicentre clinical study from May 2020 to March 2022 in China and recruited 937 patients with GC and 1911 participants with NGC from 10 centres across China to further evaluate the role of tongue images in the diagnosis of GC. Moreover, we verified this approach in another independent external validation cohort that included 294 patients with GC and 521 participants with NGC from 7 centres. This study is registered at ClinicalTrials.gov, NCT01090362.
    UNASSIGNED: For the first time, we found that both tongue images and the tongue coating microbiome can be used as tools for the diagnosis of GC, and the area under the curve (AUC) value of the tongue image-based diagnostic model was 0.89. The AUC values of the tongue coating microbiome-based model reached 0.94 using genus data and 0.95 using species data. The results of the prospective multicentre clinical study showed that the AUC values of the three tongue image-based models for GCs reached 0.88-0.92 in the internal verification and 0.83-0.88 in the independent external verification, which were significantly superior to the combination of eight blood biomarkers.
    UNASSIGNED: Our results suggest that tongue images can be used as a stable method for GC diagnosis and are significantly superior to conventional blood biomarkers. The three kinds of tongue image-based AI deep learning diagnostic models that we developed can be used to adequately distinguish patients with GC from participants with NGC, even early GC and precancerous lesions, such as atrophic gastritis (AG).
    UNASSIGNED: The National Key R&D Program of China (2021YFA0910100), Program of Zhejiang Provincial TCM Sci-tech Plan (2018ZY006), Medical Science and Technology Project of Zhejiang Province (2022KY114, WKJ-ZJ-2104), Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer (JBZX-202006), Natural Science Foundation of Zhejiang Province (HDMY22H160008), Science and Technology Projects of Zhejiang Province (2019C03049), National Natural Science Foundation of China (82074245, 81973634, 82204828), and Chinese Postdoctoral Science Foundation (2022M713203).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    UNASSIGNED:我们确定了中医(TCM)中正常高血压病的体质类型的分布,并为预防正常高血压病和高血压提供了证据。
    UNASSIGNED:从2011年1月到2022年11月搜索了八个数字数据库,包括PubMed,EMBASE,WebofScience,EBSCOhost,CNKI,CBM,王芳,还有CQVIP.我们使用随机效应模型或固定效应模型进行了荟萃分析,以描述中医正常高血压的构成类型的分布。这些研究是根据异质性测试和发表偏倚的可能性进行评估的。Meta分析在Stata软件15.0上进行。
    UNASSIGNED:本荟萃分析共纳入17项研究,共8118名参与者。偏体质的比例(82.3%;95%CI:75.6%-89.1%,p<0.001)高于平衡体质(17.3%;95%CI:10.7-23.8%,p<0.001)。痰湿体质,阴虚体质,湿热体质占16.0%(95CI:10.5-21.5%,p<0.001),14.8%(95%CI:11.0-18.6%,p<0.001),11.3%(95%CI:8.0-14.5%,p<0.001)的正常高血压病例总数,分别。亚组分析执行了该区域,年龄和性别与中医正常高值血压的体质类型分布呈正相关。与普通人群相比,痰湿体质的人血压正常偏高的风险,阴虚体质,血瘀体质为2.665(95CI:2.286-3.106,p<0.001),2.378(95CI:1.197-4.724,p=0.013),普通人群的1.965(95CI:1.634-2.363,p<0.001)倍,分别。同时,体质平衡的人群出现正常高值血压的风险较低(0.248,95CI:0.165-0.372,p<0.001).
    未经批准:痰湿体质,阴虚体质,湿热体质是正常高血压的常见体质类型。不同地区正常高值血压人群的中医体质分布特征也可能存在差异,年龄,和性别。最后,平衡的体质可能是高血压患者的保护因素。
    UNASSIGNED: We determined the distribution of constitutional types of high-normal blood pressure in Traditional Chinese Medicine (TCM) and provided evidence for the prevention of high-normal blood pressure and hypertension.
    UNASSIGNED: Eight digital databases were searched from January 2011 to November 2022, including PubMed, EMBASE, Web of Science, EBSCOhost, CNKI, CBM, Wangfang, and CQVIP. We performed a meta-analysis with the random-effects model or fixed-effects model to describe the distribution of constitutional types of high-normal blood pressure in TCM. The studies were assessed based on heterogeneity testing and the potential for publication bias. The meta-analysis was performed on Stata software 15.0.
    UNASSIGNED: A total of 17 studies with 8118 participants were included in this meta-analysis. The proportion of the biased constitution (82.3%; 95% CI: 75.6%-89.1%, p < 0.001) was higher than the balanced constitution (17.3%; 95% CI: 10.7-23.8%, p < 0.001). Phlegm-dampness constitution, Yin-deficiency constitution, and damp-heat constitution accounted for 16.0% (95%CI: 10.5-21.5%, p < 0.001), 14.8% (95% CI: 11.0-18.6%, p < 0.001), 11.3% (95% CI: 8.0-14.5%, p < 0.001) of the total high-normal blood pressure cases, respectively. The subgroup analyses performed that region, age and gender were positively associated with the distribution of constitution types of high-normal blood pressure in TCM. Compared with the general population, the risk of high-normal blood pressure in people with the phlegm-dampness constitution, Yin-deficiency constitution, and blood-stasis constitution was 2.665 (95%CI: 2.286-3.106, p < 0.001), 2.378 (95%CI: 1.197-4.724, p = 0.013), 1.965 (95%CI: 1.634-2.363, p < 0.001) times of the general population, respectively. Meanwhile, the risk of high-normal blood pressure was lower in people with a balanced constitution (0.248, 95%CI: 0.165-0.372, p < 0.001).
    UNASSIGNED: Phlegm-dampness constitution, Yin-deficiency constitution, and damp-heat constitution were the common constitution types of high-normal blood pressure. There might also be differences in the distribution characteristics of TCM constitution among people with high-normal blood pressure in different regions, ages, and genders. Finally, a balanced constitution might be a protective factor for hypertensive people.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    血栓形成是复发性自然流产(RSA)的重要缘由。血栓性疾病的治疗有利于RSA的预防。因此,我们探讨了补血中药的临床疗效,补肾镇静治疗RSA合并血栓形成倾向。回顾性分析190例RSA合并血栓性疾病患者采用不同治疗方法的临床转归。中药组采用补肾法治疗,活血疏胎中药和西药组用低分子肝素(LMWH)治疗,中药联合西药组用LMWH加中药补肾,血液激活和胎儿稳定。治疗后,血小板聚集率,与单纯中药和LMWH组相比,LMWH组的血浆D-二聚体和子宫动脉血流阻力显着降低(P<0.0167)。与其他组相比,LMWH加中药组明显加快了胎儿芽的生长(P<0.0167)。此外,LMWH加中药组改善中医证候积分(P<0.0167),显现出较好的临床疗效。在治疗期间,LMWH组中有5例患者发生了不良反应,但在简单草药和LMWH加草药组中没有发生不良反应。因此,我们的研究表明,对于RSA合并血栓形成的治疗,中草药加LMWH可以改善怀孕期间子宫的血液供应,并为胎儿的生长提供有利的环境。中药具有良好的疗效,不良反应少。
    Thrombophilia is an important cause of recurrent spontaneous abortion (RSA). The treatment of thrombophilia is beneficial to the prevention of RSA. Therefore, we explored the clinical effect of Chinese traditional herbs with the effects of invigorating the blood, tonifying the kidney and calming the fetus in the treatment of RSA complicated with thrombophilia. We retrospectively analyzed the clinical outcomes of 190 RSA patients combined with thrombophilia using different treatment methods. The traditional Chinese medicine group was treated with kidney-invigorating, blood-activating and fetus-soothing herbs and the western medicine group was treated with low molecular weight heparin (LMWH), and the traditional Chinese medicine combined with western medicine group was treated with LMWH plus Chinese traditional herbs with the effects of kidney tonifying, blood activating and fetus stabilizing. After treatments, platelet aggregation rate, plasma D-dimer and uterine artery blood flow resistance were significantly reduced in the LMWH plus herbs compared to the simple herbs and LMWH group (P < 0.0167). The LMWH plus herbs group significantly accelerated the growth of fetal bud compared with other groups (P < 0.0167). Moreover, the LMWH plus herbs group improved traditional Chinese medicine syndrome scores (P < 0.0167), showing a better clinical efficacy. Adverse reactions occurred in five patients in the LMWH group but not in the simple herbs and LMWH plus herbs group during the treatment period. Therefore, our study shows that for the treatment of RSA complicated with thrombophilia, Chinese traditional herbs plus LMWH can improve the blood supply of the uterus during pregnancy and contribute to a favorable environment for the growth of the fetus. Chinese traditional herbs exert a good curative effect with few adverse reactions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经批准:人参,益气补脾的关键中药,在东亚广泛用于胃肠道疾病的治疗。在这项研究中,我们的目的是研究人参多糖(PGP)对肠粘膜修复的潜在影响和机制,这是由Ca2信号控制的粘膜损伤恢复过程中的关键修复方式之一。
    UNASSIGNED:吲哚美辛诱导大鼠肠粘膜损伤模型。通过用BrdU的免疫组织化学染色进行部分细胞迁移。还进行了肠粘膜损伤的形态学观察。采用划痕法进行肠上皮细胞(IEC-6)的体外迁移。采用Western-blot检测PLC-γ1、Rac1、TRPC1、RhoA和Cav-1的表达。免疫沉淀用于评估Rac1/PLC-γ1,RhoA/TRPC1和Cav-1/TRPC1的水平。
    UNASSIGNED:结果表明PGP有效降低了对肠粘膜损伤的评估,逆转吲哚美辛诱导的上皮细胞迁移的抑制作用,并增加了体内肠粘膜中Ca2的水平。此外,PGP显著促进IEC-6细胞迁移,在体外表达Ca2调节因子(PLC-γ1,Rac1,TRPC1,Cav-1和RhoA)以及蛋白质复合物(Rac1/PLC-γ1,Cav-1/TRPC1和RhoA/TRPC1)。
    未经证实:PGP部分通过控制Ca2+动员的调节剂增加肠粘膜中的Ca2+含量,随后促进肠上皮细胞迁移,然后防止吲哚美辛引起的肠粘膜损伤。
    UNASSIGNED: Panax ginseng, a key herbal medicine of replenishing Qi and tonifying Spleen, is widely used in the treatment of gastrointestinal diseases in East Asia. In this study, we aim to investigate the potential effects and mechanisms of polysaccharides from P. ginseng (PGP) on intestinal mucosal restitution which is one of the crucial repair modalities during the recovery of mucosal injury controlled by the Ca2+ signaling.
    UNASSIGNED: Rat model of intestinal mucosal injury was induced by indomethacin. The fractional cell migration was carried out by immunohistochemistry staining with BrdU. The morphological observations on intestinal mucosal injury were also performed. Intestinal epithelial cell (IEC-6) migration in vitro was conducted by scratch method. Western-blot was adopted to determine the expressions of PLC-γ1, Rac1, TRPC1, RhoA and Cav-1. Immunoprecipitation was used to evaluate the levels of Rac1/PLC-γ1, RhoA/TRPC1 and Cav-1/TRPC1.
    UNASSIGNED: The results showed that PGP effectively reduced the assessment of intestinal mucosal injury, reversed the inhibition of epithelial cell migration induced by Indomethacin, and increased the level of Ca2+ in intestinal mucosa in vivo. Moreover, PGP dramatically promoted IEC-6 cell migration, the expression of Ca2+ regulators (PLC-γ1, Rac1, TRPC1, Cav-1 and RhoA) as well as protein complexes (Rac1/PLC-γ1, Cav-1/TRPC1 and RhoA/TRPC1) in vitro.
    UNASSIGNED: PGP increases the Ca2+ content in intestinal mucosa partly through controlling the regulators of Ca2+ mobilization, subsequently promotes intestinal epithelial cell migration, and then prevents intestinal mucosal injury induced by indomethacin.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    国家概述:中华人民共和国国家中医药管理局(NATCM)和国家中医药管理局(TCM)倡导中药和抗病毒药物联合治疗新型冠状病毒肺炎(NCP),以提高临床治疗效果。
    UNASSIGNED:将诊断为NCP的46例患者依次分为意向治疗人群:实验组(复喜天地五兴汤联合抗病毒药物;n=23)和对照组(仅抗病毒药物)(n=23)。比较两组患者的发热持续时间,咳嗽症状评分,疲劳,食欲,呼吸困难,下床活动,胸部计算机断层扫描(CT)恢复,病毒学清除,平均住院时间,药物的临床有效率。经过6天的观察,对照组的患者被分为接受治疗的人群:获得临床获益的实验亚组(n=14)和对照组(n=9).
    未经评估:发热持续时间有显著改善(1.087±0.288vs4.304±2.490),咳嗽(0.437±0.589vs2.435±0.662;P<0.05),胸部CT评价(82.6%vs43.4%;P<0.05),与对照组相比,实验组患者的病毒学清除率(60.8%vs8.7%;P<0.05)。在接受治疗的人群中进一步观察,咳嗽(0.742±0.463vs1.862±0.347;P<0.05)和疲劳(78.5%vs33.3%;P<0.05)在现有治疗基础上明显缓解。
    UNASSIGNED:复喜天地五兴汤联合抗病毒药物的早期治疗可明显缓解NCP的临床症状,显示胸部CT扫描的改善,提高病毒学清除,缩短平均住院时间,并降低患严重疾病的风险。复喜天地五行汤在NCP中的作用可能具有临床意义,需要进一步考虑。
    UNASSIGNED: The National Administration of Traditional Chinese Medicine of the People\'s Republic of China (NATCM) and the State Administration of Traditional Chinese medicine (TCM) advocated a combination therapy of TCM and anti-viral drugs for novel coronavirus pneumonia (NCP) to improve the efficacy of clinical treatment.
    UNASSIGNED: Forty-six patients diagnosed with NCP were sequentially divided into intent-to-treat population: the experimental group (combination of FuXi-Tiandi-Wuxing Decoction and anti-viral drugs; n = 23) and the control group (anti-viral drugs only) (n = 23). The two groups were compared in terms of duration of fever, cough symptom score, fatigue, appetite, dyspnea, out-of-bed activities, chest computer tomography (CT) recovery, virological clearance, average length of hospital stay, and clinical effective rate of drug. After 6 days of observation, patients from the control group were divided into as-treated population: experimental subgroup (n = 14) to obtain clinical benefit and control subgroup (n = 9).
    UNASSIGNED: There was a significant improvement in the duration of fever (1.087 ± 0.288 vs 4.304 ± 2.490), cough (0.437 ± 0.589 vs 2.435 ± 0.662; P < 0.05), chest CT evaluation (82.6% vs 43.4%; P < 0.05), and virological clearance (60.8% vs 8.7%; P < 0.05) in patients of the experimental group compared with patients in the control group. Further observation in as-treated population reported that cough (0.742 ± 0.463 vs 1.862 ± 0.347; P < 0.05) and fatigue (78.5% vs 33.3%; P < 0.05) were significantly relieved after adding FuXi-Tiandi-Wuxing Decoction to the existing treatment.
    UNASSIGNED: An early treatment with combination therapy of FuXi-Tiandi-Wuxing Decoction and anti-viral drugs significantly relieves the clinical symptoms of NCP, shows improvement in chest CT scan, improves virological clearance, shortens average length of hospital stay, and reduces the risk of severe illness. The effect of FuXi-Tiandi-Wuxing Decoction in NCP may be clinically important and require further consideration.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经证实:骨肉瘤(OS)是骨组织中最常见的原发性恶性肿瘤,在临床实践中仍然缺乏有效的治疗方法。中药(TCM)已经使用了数千年,它为OS管理提供了很好的见解。没食子酸(GA)是一种富含各种食品和草药的天然酚酸。GA的几种药理活性,例如抗氧化和抗炎已经得到了很好的确立。然而,其在OS中的生物学功能仍未完全了解。
    未经批准:在143​B中评估了GA的潜在抗癌特性,U2OS和MG63​细胞。它对细胞生长的影响,细胞周期,在这些OS细胞中检测细胞凋亡和迁移。通过qPCR检测lncRNAH19和Wnt/β-catenin信号,荧光素酶活性和蛋白质印迹分析。使用原位小鼠模型研究了GA对肿瘤生长的体内作用。
    未经批准:在本研究中,发现GA通过诱导OS细胞的细胞周期停滞和凋亡来抑制肿瘤的生长。并抑制侵袭和转移。使用原位动物模型,还发现GA在体内抑制肿瘤发生。长链非编码RNA(lncRNA)H19被证明被GA下调,并因此破坏了OS细胞中典型的Wnt/β-连环蛋白信号传导。此外,H19的异位表达挽救了GA诱导的对肿瘤生长和转移的抑制作用,并部分逆转了Wnt/β-catenin信号的失活。
    未经批准:一起,我们的结果表明,在OS细胞中,GA通过H19介导的Wnt/β-catenin信号调节轴抑制肿瘤生长.
    UNASSIGNED:从这项研究中获得的信息提供了GA介导的抗OS活性的新的潜在机制,表明GA可能是OS患者的有希望的候选药物。
    UNASSIGNED: Osteosarcoma (OS) is the most common primary malignancy in bone tissues, and effective therapeutics remain absent in clinical practice. Traditional Chinese medicines (TCM) have been used for thousands of years, which provide great insights into OS management. Gallic acid (GA) is a natural phenolic acid enriched in various foods and herbs. Several pharmacological activities of GA such as anti-oxidation and anti-inflammation have been well-established. However, its biological function in OS remains not fully understood.
    UNASSIGNED: The potential anti-cancer properties of GA were evaluated in 143 ​B, U2OS and MG63 ​cells. Its effects on cell growth, cell cycle, apoptosis and migration were examined in these OS cells. The lncRNA H19 and Wnt/β-catenin signaling were detected by qPCR, luciferase activity and Western blotting assays. The in vivo effect of GA on tumor growth was investigated using an orthotopic mouse model.
    UNASSIGNED: In the present study, GA was found to suppress the tumor growth in vitro via inducing cell cycle arrest and apoptosis in OS cells, and inhibit the invasion and metastasis as well. Using the orthotopic animal model, GA was also found to suppress tumorigenesis in vivo. Long noncoding RNA (lncRNA) H19 was demonstrated to be down-regulated by GA, and thus disrupted the canonical Wnt/β-catenin signaling in OS cells. Furthermore, the ectopic expression of H19 rescued the GA-induced suppressive effects on tumor growth and metastasis, and partially reversed the inactivation of Wnt/β-catenin signaling.
    UNASSIGNED: Taken together, our results indicated that GA inhibited tumor growth through an H19-mediated Wnt/β-catenin signaling regulatory axis in OS cells.
    UNASSIGNED: The information gained from this study provides a novel underlying mechanism of GA mediated anti-OS activity, suggesting that GA may be a promising drug candidate for OS patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    中药注射剂(TCMI)是指利用现代技术使中成药呈可注射形式,缩短了中药的起效时间。虽然临床上曾有参麦注射液(SMI)用于治疗心血管疾病(CVDs),没有药理学实验来研究药物在体外的功效或潜在的机制。
    UNASSIGNED:我们旨在使用微电极阵列(MEA)和遗传编码的Ca2指示剂,系统地评估SMI在调节电生理和钙(Ca2)信号传导中的功效并研究其机制。GCaMP6s,分别,在人诱导的多能干细胞衍生的心肌细胞(hiPSC-CM)中。
    UNASSIGNED:采用MEA系统记录hiPSC-CM中的场电位(FP)。QT间期由RR间期校正,跳动率的倒数。GCaMP6s用于测量hiPSC-CM中的Ca2信号传导。同时,使用RNAseq检查用2%SMI处理的hiPSC-CM的转录组变化。此外,使用液相色谱-质谱(LC-MS)研究了SMI的成分。
    未经评估:发现0.5%,1%,2%(v/v)的SMI可以增加校正的QT(QTc),但不改变其他FP参数。GCaMP6s已成功用于测量SMI的慢性功能。半峰全宽(FWHM),上升时间,用SMI处理1h和24h后,衰减时间显着减少,而观察到Ca2+瞬态频率增加。
    UNASSIGNED:我们首先使用Ca2+指标来测量中医的慢性效应。我们发现SMI治疗可以调节电生理和钙信号并调节氧化磷酸化,心肌收缩,
    Traditional Chinese medicine injection (TCMI) refers to the use of modern technology to make Chinese patent medicines in injectable forms, which shorten the onset time of the traditional Chinese medicine (TCM). Although there have been clinical cases in which Shenmai injection (SMI) was used to treat cardiovascular diseases (CVDs), there are no pharmacological experiments that investigate the efficacy of the drug in vitro or the underlying mechanisms.
    UNASSIGNED: We aimed to systemically evaluate the efficacy and investigate the mechanisms of SMI in modulating electrophysiology and calcium (Ca2+) signaling using a microelectrode array (MEA) and a genetically encoded Ca2+ indicator, GCaMP6s, respectively, in human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).
    UNASSIGNED: A MEA system was employed to record field potentials (FPs) in hiPSC-CMs. The QT interval is corrected by the RR interval, the reciprocal of the beating rate. GCaMP6s was used to measure Ca2+ signaling in hiPSC-CMs. Meanwhile, the transcriptome changes in hiPSC-CMs treated with 2% SMI were examined using RNAseq. In addition, the ingredients of SMI were investigated using liquid chromatography-mass spectrometry (LC-MS).
    UNASSIGNED: It was found that 0.5%, 1%, and 2% (v/v) SMIs could increase corrected QT (QTc) but did not change other FP parameters. GCaMP6s was successfully applied to measure the chronic function of SMI. The full width at half maximum (FWHM), rise time, and decay time significantly decreased after treatment with SMI for 1 h and 24 h, whereas an increased Ca2+ transient frequency was observed.
    UNASSIGNED: We first used the Ca2+ indicator to measure the chronic effects of TCM. We found that SMI treatment can modulate electrophysiology and calcium signaling and regulate oxidative phosphorylation, cardiac muscle contraction, and the cell cycle pathway in hiPSC-CMs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    COVID-19是近年来影响全球大多数人的最具破坏性的疾病。SARS-CoV-2的更高的传播率和突变率以及缺乏潜在的治疗方法使其成为全球危机。来自天然来源的潜在分子可能是对抗COVID-19的有效补救措施。本系统综述强调了天然存在的甘草酸及其相关衍生物对COVID-19的详细治疗意义。甘草甜素已经被确定用于阻断与SARS-CoV-2复制周期相关的不同生物分子靶标。在这篇文章中,已经详细讨论了甘草酸及其相关衍生物的一些实验和理论证据,以评估其作为抗COVID-19的有希望的治疗策略的潜力。此外,综述了中药中甘草酸对减轻COVID-19症状的作用。还详细讨论了甘草甜素和相关化合物在影响SARS-CoV-2生命周期的各个阶段中的潜在作用。甘草酸的衍生化用于设计潜在的先导化合物,以及与其他抗SARS-CoV-2药物的联合疗法,然后进行广泛的评估,可能有助于制定新型抗冠状病毒疗法,以更好地治疗COVID-19。
    COVID-19 is the most devastating disease in recent times affecting most people globally. The higher rate of transmissibility and mutations of SARS-CoV-2 along with the lack of potential therapeutics has made it a global crisis. Potential molecules from natural sources could be a fruitful remedy to combat COVID-19. This systematic review highlights the detailed therapeutic implication of naturally occurring glycyrrhizin and its related derivatives against COVID-19. Glycyrrhizin has already been established for blocking different biomolecular targets related to the SARS-CoV-2 replication cycle. In this article, several experimental and theoretical evidences of glycyrrhizin and related derivatives have been discussed in detail to evaluate their potential as a promising therapeutic strategy against COVID-19. Moreover, the implication of glycyrrhizin in traditional Chinese medicines for alleviating the symptoms of COVID-19 has been reviewed. The potential role of glycyrrhizin and related compounds in affecting various stages of the SARS-CoV-2 life cycle has also been discussed in detail. Derivatization of glycyrrhizin for designing potential lead compounds along with combination therapy with other anti-SARS-CoV-2 agents followed by extensive evaluation may assist in the formulation of novel anti-coronaviral therapy for better treatment to combat COVID-19.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    中医是解开中华文明瑰宝的钥匙。中药及其复方在医疗活动中发挥有益作用,特别是在全球范围内的新型冠状病毒流行等重大公共卫生事件中。中药配方中的化学成分复杂多样,但它们的有效物质类似于“神秘盒子”。揭示其活性成分及其作用机理已成为中药学家研究的重点和难点。尽管现有的研究方法很多,并且不断迭代更新,仍然缺乏前瞻性审查。因此,本文在以往研究的基础上,从体外到体内的角度,全面介绍了现有的新方法和技术。此外,还揭示了中药配方有效物质研究的瓶颈。尤其是,我们展望新的观点,未来发展的技术和应用。这项工作基于新的视角进行了回顾,为未来的研究开辟了视野。因此,中药复方药物研究应在追求领域创新的同时,继承中药的精髓。
    Traditional Chinese medicine (TCM) is the key to unlock treasures of Chinese civilization. TCM and its compound play a beneficial role in medical activities to cure diseases, especially in major public health events such as novel coronavirus epidemics across the globe. The chemical composition in Chinese medicine formula is complex and diverse, but their effective substances resemble \"mystery boxes\". Revealing their active ingredients and their mechanisms of action has become focal point and difficulty of research for herbalists. Although the existing research methods are numerous and constantly updated iteratively, there is remain a lack of prospective reviews. Hence, this paper provides a comprehensive account of existing new approaches and technologies based on previous studies with an in vitro to in vivo perspective. In addition, the bottlenecks of studies on Chinese medicine formula effective substances are also revealed. Especially, we look ahead to new perspectives, technologies and applications for its future development. This work reviews based on new perspectives to open horizons for the future research. Consequently, herbal compounding pharmaceutical substances study should carry on the essence of TCM while pursuing innovations in the field.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号